Combatting the Rising Rates of NTM Pulmonary Disease
Updated NTM pulmonary disease estimates in U.S. Medicare beneficiaries revealed rising incidence, demographic disparities, and associated comorbidities.
Read More
Author: Teresa Sellinger
Defining the Standard of Care in Medical Malpractice
The standard of care definition can vary during medical malpractice cases, and physicians must prove they acted in accordance with good, accepted practice.
Read More
Identifying Factors to Differentiate Ménière’s Disease from Vestibular Migraine
Dissociation between a video head impulse test and reduced caloric response had high specificity for differentiating vestibular migraine from Ménière’s disease.
Read More
Frequent Testing for Driver Mutations Critical in Myelofibrosis
Machine learning is effective for differentiating chronic myeloid leukemia from polycythemia vera, primary myelofibrosis, and essential thrombocythemia.
Read More
Urine ACR Independently Predicts Mortality in RA
ACR was a key indicator of risk for mortality in RA with chronic renal insufficiency, predicting all-cause mortality better than eGFR.
Read More
AAP: Why Literacy Promotion is Crucial During Clinical Visits
An updated American Academy of Pediatrics statement on literacy promotion in clinical visits emphasizes shared reading, reduced screen time, and diversity.
Read More
Energy Expenditure Feedback Boosts Weight Loss
Personalized energy expenditure data significantly improved weight loss outcomes in patients with obesity, enhancing adherence to lifestyle interventions.
Read More
Helping Patients Understand “Wants” Versus “Needs”
Patients have easy access to health information, so doctors must enhance efforts involving helping patients understand their conditions and treatment options.
Read More
Leveraging Nonverbal Cues to Build Trust & Improve Patient Care
How clinicians can use subtle nonverbal cues to convey interest and authority to patients, which can help build trust and improve the efficiency of visits.
Read More
Gut Microbiota Modulates Inflammation & Cortical Damage
In a recent study, Alistipes onderdonkii, had a positive association with cerebral leptomeningeal enhancement in patients with MS.
Read More
B-Cell-Tailored Dosing of Ocrelizumab Yields Encouraging Results
Patients with relapsing-remitting MS showed promising results with B-cell-tailored dosing of ocrelizumab.
Read More
Addressing Non-Adherence & Motivating Patients
For patients with HIV, many factors may influence medication adherence throughout multiple points of their disease course.
Read More
Encouraging Real-World Results of AHSCT to Treat Aggressive MS
Patients with severe forms of MS had encouraging results with a autologous hematopoietic stem cell transplantation in a large-scale real-world cohort.
Read More
High-Dose Simvastatin Does Not Slow Disability Progression in SPMS
The MS-STAT2 trial of a high-dose simvastatin has failed to slow progression of disability in patients with secondary progressive MS.
Read More
Tolebrutinib Slows Disability Worsening in Relapsing MS
Patients with multiple sclerosis found that their symptoms did not worsen with intake of tolebrutinib, in the GEMINI 1 and 2 studies.
Read More
Why It’s Important to Discuss Sexual Health With Patients
Illness and physical challenges may affect a patient’s ability to engage in sexual activity. For patients with MS, this might be due to fatigue or disability.
Read More
An Easy Way to Identify Disability in Older Adults With RA
Researchers examined the link between LS and grip strength in RA, noting the importance of physical function as a key factor in managing aging populations.
Read More
Empower Patients by Supporting Their Desire for a Second Opinion
Although a patient’s request for a second opinion can make a physician question the patient’s trust level, physicians should consider supporting that desire.
Read More
Fecal Transplants Show Promise in Enhancing Metastatic RCC Treatment
Fecal microbiota transplantation has significantly improved progression-free survival in patients with metastatic renal cell carcinoma.
Read More
Adding Lenvatinib Plus Pembrolizumab to TACE Improves Survival in Intermediate-Stage Hepatocellular Cancer
Lenvatinib plus pembrolizumab has improved survival rates for patients with intermediate-stage hepatocellular cancer, LEAP-012 study finds.
Read More